The COVID-19 pandemic has highlighted the immense risk potential posed by (re‑)emerging viruses. There are neither approved vaccines nor specific therapies for many of these viruses. This is precisely where DEFENDER (IDEntification oF novel viral Entry factors aNd DevelopmEnt of antiviRal approaches) comes in: The project aims to develop new, alternative antiviral approaches in order to be prepared for future outbreaks.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://defender-project.org/
- Competitors
- Famiglia Desideri - Cialde di Montecatini Terme, Research Training Group 2633, Leibniz-Institut für Virologie (LIV), WHO Hub for Pandemic and Epidemic Intelligence, Junior Section SFBBM, Defender Pro LLC, SHIELD - Molecular Strategies against Viral Entry and Glycan Shielding, European Centre for Disease Prevention and Control (ECDC), Hotel Montecatini Terme-Tuscany, Insempra.
Defender Questions
Defender's website is https://defender-project.org/
Defender's LinkedIn profile is https://www.linkedin.com/company/defender-project
Defender's industry is
Biotechnology Research
Defender's top competitors are
Famiglia Desideri - Cialde Di Montecatini Terme,
Research Training Group 2633,
Leibniz-Institut Für Virologie (Liv),
Who Hub For Pandemic And Epidemic Intelligence,
Junior Section Sfbbm,
Defender Pro Llc,
Shield - Molecular Strategies Against Viral Entry And Glycan Shielding,
European Centre For Disease Prevention And Control (Ecdc),
Hotel Montecatini Terme-Tuscany,
Insempra.
Defender's categories are Biotechnology Research
